Inspira Technologies OXY B.H.N. (NASDAQ:IINN) Shares Down 5.3% – What’s Next?

Shares of Inspira Technologies OXY B.H.N. Ltd. (NASDAQ:IINN) fell 5.3% on Thursday . The stock traded as low as $1.39 and last traded at $1.42. Approximately 1,702,811 shares were traded during mid-day trading, an increase of 383% from the average daily volume of 352,435 shares. The stock had previously closed at $1.50.

Analyst Ratings Changes

Separately, Weiss Ratings reiterated a “sell (e+)” rating on shares of Inspira Technologies OXY B.H.N. in a research report on Friday, April 10th. One analyst has rated the stock with a Sell rating, Based on data from MarketBeat.com, Inspira Technologies OXY B.H.N. has a consensus rating of “Sell”.

Inspira Technologies OXY B.H.N. Price Performance

The business has a fifty day moving average price of $1.45 and a 200-day moving average price of $0.92. The company has a quick ratio of 1.30, a current ratio of 1.56 and a debt-to-equity ratio of 0.08.

Institutional Trading of Inspira Technologies OXY B.H.N.

Several hedge funds and other institutional investors have recently bought and sold shares of IINN. Kestra Advisory Services LLC purchased a new position in shares of Inspira Technologies OXY B.H.N. during the fourth quarter worth approximately $71,000. Citadel Advisors LLC purchased a new stake in shares of Inspira Technologies OXY B.H.N. in the 3rd quarter valued at $105,000. Finally, Yorkville Advisors Global LP purchased a new stake in shares of Inspira Technologies OXY B.H.N. in the 4th quarter valued at $1,605,000. Hedge funds and other institutional investors own 12.72% of the company’s stock.

About Inspira Technologies OXY B.H.N.

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation for the treatment of acute respiratory failure. Its lead product is the augmented respiration technology system, a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels.